(3-Fluoro-4-morpholin-4-ylphenyl)carbamic Acid Methyl Ester
- CAS
- 212325-40-1
- Formula
- C12H15FN2O3
- MW
- 254.26 g/mol
VQ-038066
Impurity reference standards
Linezolid impurities & reference standards
Characterised Linezolid impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
58reference materials
2nitrosamine impurities
2isotope-labelled
COAHPLC · NMR · MS on request
(R)-(3-(4-Morpholinophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate
- CAS
- 556801-09-3
- Formula
- C15H20N2O6S
- MW
- 356.4 g/mol
VQ-048900
(S)-(3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate
- CAS
- 2180621-71-8
- Formula
- C15H19FN2O6S
- MW
- 374.4 g/mol
VQ-038068
(S)-N-(3-((3-Fluoro-4-morpholinophenyl)amino)-2-hydroxypropyl)acetamide
- CAS
- 1561176-27-9
- Formula
- C15H22FN3O3
- MW
- 311.35 g/mol
VQ-031587
![(S)-N-[[3-(3-Fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl]methyl]benzylamine hydrochloride chemical structure](/media/structures/LOFRLWMLERNDKD-FERBBOLQSA-N.svg)
(S)-N-[[3-(3-Fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl]methyl]benzylamine hydrochloride
- CAS
- 1236077-63-6
- Formula
- C21H25ClFN3O3
- MW
- 421.9 g/mol
VQ-038070
![[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methanol chemical structure](/media/structures/OLDRPBWULXUVTL-LLVKDONJSA-N.svg)
[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methanol
- CAS
- 168828-82-8
- Formula
- C14H17FN2O4
- MW
- 296.29 g/mol
VQ-038062
1-(3-Fluoro-4-morpholinophenyl)-2-methyl-1,4,5,6-tetrahydropyrimidin-5-ol
- CAS
- 2512211-93-5
- Formula
- C15H20FN3O2
- MW
- 293.34 g/mol
VQ-038072
Linezolid Desacetamide Descarbonyl Phthalimide (R)-Isomer
- CAS
- 874340-08-6
- Formula
- C21H22FN3O4
- MW
- 399.4 g/mol
VQ-031585
Linezolid Desacetamide Descarbonyl Phthalimide Desfluoro (R)-Isomer
- CAS
- 1798887-61-2
- Formula
- C21H23N3O4
- MW
- 381.4 g/mol
In stock
Linezolid Desacetamide Hydroxy Impurity (S-isomer)
- CAS
- 2180529-06-8
- Formula
- C14H17FN2O4
- MW
- 296.29 g/mol
VQ-031589
Linezolid Descarbonyl N-Desacetyl N-Acetyl Hydrochloride
- CAS
- 1391068-25-9
- Formula
- C15H23ClFN3O3
- MW
- 347.81 g/mol
VQ-031582
N-(3-((3-Fluoro-4-morpholinophenyl)amino)-2-hydroxypropyl)acetamide
- CAS
- 1666111-36-9
- Formula
- C15H22FN3O3
- MW
- 311.35 g/mol
VQ-038074
![N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide chemical structure](/media/structures/TYZROVQLWOKYKF-UHFFFAOYSA-N.svg)
N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide
- CAS
- 224323-50-6
- Formula
- C16H20FN3O4
- MW
- 337.35 g/mol
VQ-038063
N-Desacetyl-N,O-descarbonyl O-Acetyl Linezolid
- CAS
- 333753-71-2
- Formula
- C15H22FN3O3
- MW
- 311.35 g/mol
VQ-031586
N-Desacetyl-N,O-descarbonyl O-Acetyl Linezolid Hydrochloride
- CAS
- 2055572-73-9
- Formula
- C15H23ClFN3O3
- MW
- 347.81 g/mol
VQ-038065
N,N Bis(3-fluoro-4-(4-morpholinyl phenyl)urea
- CAS
- 2819018-79-4
- Formula
- C21H24F2N4O3
- MW
- 418.4 g/mol
VQ-048901
FAQs — Linezolid impurities
Which Linezolid impurities do you supply?
We list 58 Linezolid-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Linezolid impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Linezolid impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Linezolid impurity standards
We reply within one business day with price, pack options, lead time and documentation.